CCN3 and myeloid sarcoma: To this end, we conducted extensive profiling of CCN3 expression in healthy and MS disease states to answer whether CCN3 is dysregulated in MS and determine whether there is rationale for CCN3-mediated regenerative mechanisms as a therapeutic target for neurological disease.